STENOCARE A/S: Financial statements 2019
CVR: 39024705
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
STENOCARE A/S (CVR 39024705) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 8,784,408 and a net result of DKK 1,702,421. Equity in the 2019 report amounted to DKK 13,474,618. The solvency ratio was 42.6%. The company had 6 employees in the financial year.
- Gross Profit
- DKK 8,784,408
- Profit/Loss
- DKK 1,702,421
- Equity
- DKK 13,474,618
- Total Assets
- DKK 31,608,373
- Employees
- 6
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of September 5, 2019, Ian Abramowitz has left the board of directors of STENOCARE A/S.
STENOCARE A/S has published its interim report for the period October 19, 2017 – December 31, 2018.
As of May 16, 2019, Ian Abramowitz has joined the board of directors of STENOCARE A/S.
About STENOCARE A/S
STENOCARE A/S is a Danish company of the type Aktieselskab based in Værløse, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named StenoCare A/S and StenoCare ApS. The management consists of Thomas Skovlund Schnegelsberg. The board consists of Marianne Wier (chair), Henrik Elbæk, Jeppe Bo Petersen and Rolf Steno Petersen. The company is owned by HHTM ApS and SC-Founders Holding ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 1,222,982 and a net result of DKK -2,390,531 compared with DKK -34,488,405 the year before. Equity in the 2025 report amounted to DKK 9,472,962.